oxycodone CR OxyContin
Selected indexed studies
- Oxycodone for cancer-related pain. (Cochrane Database Syst Rev, 2017) [PMID:28829910]
- Oxycodone for cancer-related pain. (Cochrane Database Syst Rev, 2022) [PMID:35679121]
- A Comparison of Daily Average Consumption Of Oxycodone Controlled Release (OxyContin CR) And Oxymorphone Extended Release (Opana ER) In Patients With Low Back Pain. (P T, 2011) [PMID:21572765]
_Worker-drafted node — pending editorial review._
Connections
oxycodone CR OxyContin is a side effect of
Sources
- Oxycodone versus morphine for cancer pain titration: A systematic review and pharmacoeconomic evaluation. (2020) pubmed
- Oxycodone for cancer-related pain. (2017) pubmed
- Oxycodone for cancer-related pain. (2022) pubmed
- A Comparison of Daily Average Consumption Of Oxycodone Controlled Release (OxyContin CR) And Oxymorphone Extended Release (Opana ER) In Patients With Low Back Pain. (2011) pubmed
- Controlled-release oxycodone-induced seizures. (2005) pubmed
- Oxycodone for cancer-related pain. (2015) pubmed
- Normal-release and controlled-release oxycodone: pharmacokinetics, pharmacodynamics, and controversy. (2003) pubmed
- Oxycodone. Pharmacological profile and clinical data in chronic pain management. (2005) pubmed
- Successful interventions in decreasing oxycodone CR prescriptions within an underserved population. (2015) pubmed
- The effect of FDA approval of a generic competitor to OxyContin (oxycodone HCl controlled-release) tablets on the abuse of oxycodone. (2006) pubmed